Classic view of this page
Comprehensive Panel for Individualized Cancer Threatment
Clinical Genetic Test
Help
offered by
GeneKor MSA
View lab's test page
LinkOut
GTR Test Accession: Help GTR000527980.1
CANCERINHERITED DISEASEHEMATOLOGY ... View more
Last updated in GTR: 2015-09-01
View version history
Last annual review date for the lab: 2023-07-21 LinkOut
At a Glance
Test purpose: Help
Drug Response; Mutation Confirmation; Pre-symptomatic; ...
Conditions (16): Help
Solid tumor; Acute lymphoid leukemia; Acute myeloid leukemia; ...
Genes (52): Help
ABL1 (9q34.12), AKT1 (14q32.33), ALK (2p23.2-23.1), APC (5q22.2), ATM (11q22.3), ...
Methods (4): Help
Molecular Genetics - Deletion/duplication analysis: Next-Generation (NGS)/Massively parallel sequencing (MPS); ...
Target population: Help
Cancer patients with diverse solid tumors and hematological malignancies
Clinical validity: Help
Not provided
Clinical utility: Help
Not provided
Ordering Information
Offered by: Help
GeneKor MSA
View lab's website
View lab's test page
Test short name: Help
Com.Pl.i.t. DX 54 genes
Specimen Source: Help
Who can order: Help
  • Genetic Counselor
  • Health Care Provider
  • Licensed Physician
  • Physician Assistant
  • Public Health Mandate
Lab contact: Help
Vasiliki Metaxa-Mariatou, MSc, Molecular Biologist & QA Manager
bmetaxa@genekor.com
+30 210 6032138
Eirini Papadopoulou, PhD, Group Leader of Oncogenetics
eirinipapad@genekor.com
+30 210 6032138
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Order URL
Test service: Help
Clinical Testing/Confirmation of Mutations Identified Previously
Informed consent required: Help
No
Pre-test genetic counseling required: Help
No
Post-test genetic counseling required: Help
No
Recommended fields not provided:
Test Order Code, Test strategy, Test development
Conditions Help
Total conditions: 16
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 52
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 4
Method Category Help
Test method Help
Instrument
Deletion/duplication analysis
Next-Generation (NGS)/Massively parallel sequencing (MPS)
The Ion Proton™ System
Mutation scanning of select exons
Next-Generation (NGS)/Massively parallel sequencing (MPS)
Sequence analysis of select exons
Next-Generation (NGS)/Massively parallel sequencing (MPS)
The Ion Proton™ System
Targeted variant analysis
Next-Generation (NGS)/Massively parallel sequencing (MPS)
The Ion Proton™ System
Clinical Information
Test purpose: Help
Drug Response; Mutation Confirmation; Pre-symptomatic; Predictive; Prognostic; Risk Assessment; Therapeutic management
Target population: Help
Cancer patients with diverse solid tumors and hematological malignancies
Variant Interpretation:
Are family members with defined clinical status recruited to assess significance of VUS without charge? Help
No.

Will the lab re-contact the ordering physician if variant interpretation changes? Help
Yes.
Recommended fields not provided:
Clinical validity, Clinical utility, What is the protocol for interpreting a variation as a VUS?, Is research allowed on the sample after clinical testing is complete?, Sample negative report, Sample positive report
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
yes 100%
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Alternative Assessment

PT Provider: Help
European Molecular Genetics Quality Network, EMQN

Description of PT method: Help
and - UK NEQAS Molecular Genetics, Colorectal Cancer & Lung Cancer schemes - College of American Pathologists (CAP), MTP (Multigene Tumor Panel) & KIT/PDGFRA schemes
Recommended fields not provided:
Test Confirmation, Assay limitations, Description of internal test validation method, Citations for Analytical validity, Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review: Help
Not provided
Additional Information
Consumer resources:

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.